NCT03613402View on ClinicalTrials.gov

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 30, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Venous Thromboses
Trial Locations (1)

27705

Durham, Durham

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT03613402 - BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes | Biotech Hunter | Biotech Hunter